Synthesis and Pharmacological Evaluation of Isoindolo[1,2-b]quinazolinone and Isoindolo[2,1-a]benzimidazole Derivatives Related to the Antitumor Agent Batracylin

The synthesis and pharmacological activity of isoindolo[1,2-b]quinazolin-12(10H)-ones and isoindolo[2,1-a]benzimidazoles related to batracylin are described. The acute toxicity of batracyclin has been associated with the formation of its N-acetyl metabolite which is a potent inducer of unscheduled D...

Full description

Saved in:
Bibliographic Details
Published inJournal of medicinal chemistry Vol. 37; no. 20; pp. 3434 - 3439
Main Authors Meegalla, Sanath K, Stevens, Gregory J, McQueen, Charlene A, Chen, Allan Y, Yu, Chiang, Liu, Leroy F, Barrows, Louis R, LaVoie, Edmond J
Format Journal Article
LanguageEnglish
Published WASHINGTON American Chemical Society 01.09.1994
Amer Chemical Soc
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The synthesis and pharmacological activity of isoindolo[1,2-b]quinazolin-12(10H)-ones and isoindolo[2,1-a]benzimidazoles related to batracylin are described. The acute toxicity of batracyclin has been associated with the formation of its N-acetyl metabolite which is a potent inducer of unscheduled DNA synthesis in rat hepatocytes. The desamino derivative and the 8-aza analog of batracylin retained the ability to inhibit topoisomerase II but did not induce unscheduled DNA synthesis. While less active than batracylin, these analogs were cytotoxic to CCRF CEM leukemia cells. The isoindolo[2,1-a]benzimidazole derivatives were inactive as topoisomerase II inhibitors and, in general, failed to exhibit comparable antitumor activity or to induce unscheduled DNA synthesis.
Bibliography:istex:8F0FEF6BCF49F4307098D3A2BB844F786896F1C9
ark:/67375/TPS-HS65Q9SM-L
Medline
ISSN:0022-2623
1520-4804
DOI:10.1021/jm00046a028